Biotech Series A Investors & VC Firms
1596 firms in this list, with a median first check of $500K. 341 of them lead rounds. Generated from verified public data and updated continuously.
ExSight Ventures
Pre-Seed–Series B
4 people
OCCIDENT
MunichPre-Seed–Series A
4 people
Pappas Capital
Research Triangle ParkSeed–Late Stage$100K – $6M
7 people
BlueOcean Ventures
GenevaPre-Seed–Series A$270K – $1.4M
6 people
Iron Wolf Capital
VilniusPre-Seed–Series A$540K – $5.4M
Kendall Capital Partners
BostonSeed–Growth
6 people
Longwall Venture Partners LLP
HarwellSeed–Series A$2M
6 people
Nucleus Adventure Capital
Pre-Seed–Series A
3 people
Vertex Ventures HC
SingaporeSeed–Growth$500K – $10M
6 people
Altium Capital
New YorkSeed–Growth
5 people
Curie Capital
AmsterdamSeed–Series A
8 people
Thundermark Capital
San JuanPre-Seed–Series A
8 people
Neo Kuma Ventures
LondonPre-Seed–Series A$195K – $1.3M
7 people
Newlin Investment Company LLC
PittsburghSeed–Growth$100K – $3M
4 people
Ono Venture Investment, Inc.
South San FranciscoSeed–Series B
6 people
Unfold Ventures
WrocławPre-Seed–Late Stage$110K – $1.1M
6 people
Wallonie Entreprendre
LiègePre-Seed–Late Stage
9 people
Amzak Health
New YorkSeed–Late Stage
5 people
Tet Ventures
BerlinPre-Seed–Series A$50K – $250K
1 person
EGORA Ventures AG
MartinsriedPre-Seed–Series B$5.4M
7 people
VIVES Partners
WavrePre-Seed–Series B$108K – $7.6M
4 people
Crossbeam Venture Partners
New YorkPre-Seed–Late Stage$1M – $1.5M
3 people
MEDA Ventures
ArlingtonSeed–Series A
9 people
SIDBI Venture Capital
MumbaiSeed–Late Stage
6 people
Related lists
Series A Investors & VC Firms (7875)Series A Investors & VC Firms in United States (3337)SaaS Series A Investors & VC Firms (2667)AI & Machine Learning Series A Investors & VC Firms (2343)Enterprise Software Series A Investors & VC Firms (2324)Fintech Series A Investors & VC Firms (2239)Healthtech Series A Investors & VC Firms (2210)Series A Investors & VC Firms in Global (2163)Biotech Investors & VC Firms (2107)Biotech Seed Investors & VC Firms (1754)
Data sourced from public filings and firms' own websites — see our methodology.
















































